BR9814055B1 - composto, composição farmacêutica, uso do composto, e, processos para preparar e para produzir um composto. - Google Patents
composto, composição farmacêutica, uso do composto, e, processos para preparar e para produzir um composto.Info
- Publication number
- BR9814055B1 BR9814055B1 BRPI9814055-8A BR9814055A BR9814055B1 BR 9814055 B1 BR9814055 B1 BR 9814055B1 BR 9814055 A BR9814055 A BR 9814055A BR 9814055 B1 BR9814055 B1 BR 9814055B1
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- preparing
- processes
- producing
- pharmaceutical composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000000043 antiallergic agent Substances 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- QDEVEJYEXBFIJD-UHFFFAOYSA-N triazolo[4,5-i][1]benzazepine Chemical class C1=CC2=CC=CC=NC2=C2C1=NN=N2 QDEVEJYEXBFIJD-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26461197 | 1997-09-29 | ||
JP5206398 | 1998-03-04 | ||
PCT/JP1998/004363 WO1999016770A1 (fr) | 1997-09-29 | 1998-09-29 | Derives de triazolobenzazepine tricyclique, leur procede de production et antiallergique |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9814055A BR9814055A (pt) | 2000-09-26 |
BR9814055B1 true BR9814055B1 (pt) | 2009-05-05 |
Family
ID=26392670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9814055-8A BR9814055B1 (pt) | 1997-09-29 | 1998-09-29 | composto, composição farmacêutica, uso do composto, e, processos para preparar e para produzir um composto. |
Country Status (25)
Country | Link |
---|---|
US (3) | US6372735B1 (pt) |
EP (1) | EP1026167B1 (pt) |
JP (1) | JP3188482B2 (pt) |
KR (1) | KR100389140B1 (pt) |
CN (2) | CN1155599C (pt) |
AT (1) | ATE233764T1 (pt) |
AU (1) | AU744636B2 (pt) |
BR (1) | BR9814055B1 (pt) |
CA (1) | CA2305307C (pt) |
DE (1) | DE69811930T2 (pt) |
DK (1) | DK1026167T3 (pt) |
ES (1) | ES2191963T3 (pt) |
HK (1) | HK1032782A1 (pt) |
HU (1) | HUP0004020A3 (pt) |
ID (1) | ID24101A (pt) |
IL (1) | IL135303A0 (pt) |
NO (2) | NO319542B1 (pt) |
NZ (1) | NZ503601A (pt) |
PL (1) | PL339544A1 (pt) |
PT (1) | PT1026167E (pt) |
RU (1) | RU2198885C2 (pt) |
SK (1) | SK283869B6 (pt) |
TR (1) | TR200000808T2 (pt) |
TW (1) | TW510902B (pt) |
WO (1) | WO1999016770A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE469902T1 (de) * | 2001-12-26 | 2010-06-15 | Meiji Seika Kaisha | Amorphe substanz eines tricyclischen triazolobenzazepinderivats |
US7238719B2 (en) | 2002-02-01 | 2007-07-03 | Meiji Seika Kaisha, Ltd. | Process for producing 1,2,3-Triazole compounds |
JP4579681B2 (ja) | 2002-07-09 | 2010-11-10 | ブリストル−マイヤーズ スクイブ カンパニー | 抗糖尿病薬および抗肥満薬として有用な置換ヘテロシクロ誘導体および方法 |
BR0312503A (pt) | 2002-07-09 | 2007-06-26 | Bristol Myers Squibb Co | derivados heterocìclicos substituìdos úteis como agentes antidiabéticos e antiobesidade, composição farmacêutica, uso e combinação dos mesmos |
US20070167432A1 (en) * | 2003-06-19 | 2007-07-19 | Meiji Seila Kaisha, Ltd | Tricyclic triazolobenzapine derivative produced as novel crystalline substance |
WO2004113451A1 (ja) * | 2003-06-20 | 2004-12-29 | Meiji Seika Kaisha, Ltd. | 難溶性物質と水溶性高分子との共沈物およびその製造方法 |
EA012112B1 (ru) | 2004-05-14 | 2009-08-28 | Миллениум Фармасьютикалз, Инк. | Соединения и способы для ингибирования митотической прогрессии |
BRPI0708448A2 (pt) * | 2006-03-02 | 2011-06-07 | Meiji Seika Kaisha | composição farmacêutica, método para a profilaxia ou tratamento de doenças oftálmicas alérgicas ou doenças nasais alérgicas, e, uso de um composto |
EP2094711B8 (de) * | 2006-09-25 | 2018-03-28 | Forschungsverbund Berlin e.V. | Strukturmimetika prolinreicher peptide und ihre pharmazeutische verwendung |
CL2007003244A1 (es) | 2006-11-16 | 2008-04-04 | Millennium Pharm Inc | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. |
ATE497386T1 (de) | 2007-12-18 | 2011-02-15 | Meiji Seika Kaisha | Vorbeuge- oder heilmittel für entzündliche darmerkrankungen |
WO2010074724A1 (en) | 2008-12-22 | 2010-07-01 | Millennium Pharmaceuticals, Inc. | Combination of aurora kinase inhibitors and anti-cd20 antibodies |
JO3635B1 (ar) | 2009-05-18 | 2020-08-27 | Millennium Pharm Inc | مركبات صيدلانية صلبة وطرق لانتاجها |
WO2011084848A2 (en) | 2010-01-07 | 2011-07-14 | Alkermes, Inc. | Prodrugs of heteraromatic compounds |
CN102770024A (zh) | 2010-02-19 | 2012-11-07 | 米伦纽姆医药公司 | 4-{[9-氯-7-(2-氟-6-甲氧基苯基)-5h-嘧啶并[5,4-d][2]苯并氮杂卓-2基]氨基}-2-甲氧基苯甲酸钠的结晶形式 |
US20130303519A1 (en) | 2012-03-20 | 2013-11-14 | Millennium Pharmaceuticals, Inc. | Methods of treating cancer using aurora kinase inhibitors |
EP2976086B1 (en) | 2013-03-22 | 2020-10-14 | Millennium Pharmaceuticals, Inc. | Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995018130A1 (fr) * | 1993-12-28 | 1995-07-06 | Meiji Seika Kabushiki Kaisha | Derives tricycliques de benzazepine et benzothiazepine |
WO1997000258A1 (fr) * | 1995-06-15 | 1997-01-03 | Meiji Seika Kabushiki Kaisha | Composes de benzazepine tricyclique |
CA2247453A1 (en) * | 1996-03-08 | 1997-09-12 | Joseph James Lewis | Azolobenzazepine derivatives as neurologically active agents |
US20070059533A1 (en) * | 2005-09-12 | 2007-03-15 | Burdette Steven R | Thermal reflow of glass and fused silica body |
-
1998
- 1998-09-29 TR TR2000/00808T patent/TR200000808T2/xx unknown
- 1998-09-29 ES ES98944289T patent/ES2191963T3/es not_active Expired - Lifetime
- 1998-09-29 NZ NZ503601A patent/NZ503601A/en unknown
- 1998-09-29 EP EP98944289A patent/EP1026167B1/en not_active Expired - Lifetime
- 1998-09-29 AU AU91869/98A patent/AU744636B2/en not_active Ceased
- 1998-09-29 ID IDW20000808A patent/ID24101A/id unknown
- 1998-09-29 CA CA002305307A patent/CA2305307C/en not_active Expired - Fee Related
- 1998-09-29 RU RU2000111517/04A patent/RU2198885C2/ru not_active IP Right Cessation
- 1998-09-29 PT PT98944289T patent/PT1026167E/pt unknown
- 1998-09-29 DE DE69811930T patent/DE69811930T2/de not_active Expired - Lifetime
- 1998-09-29 IL IL13530398A patent/IL135303A0/xx unknown
- 1998-09-29 TW TW087116198A patent/TW510902B/zh not_active IP Right Cessation
- 1998-09-29 AT AT98944289T patent/ATE233764T1/de active
- 1998-09-29 CN CNB98810735XA patent/CN1155599C/zh not_active Expired - Fee Related
- 1998-09-29 US US09/509,494 patent/US6372735B1/en not_active Expired - Lifetime
- 1998-09-29 CN CNB2003101047539A patent/CN1312135C/zh not_active Expired - Fee Related
- 1998-09-29 JP JP51996999A patent/JP3188482B2/ja not_active Expired - Fee Related
- 1998-09-29 SK SK425-2000A patent/SK283869B6/sk unknown
- 1998-09-29 HU HU0004020A patent/HUP0004020A3/hu unknown
- 1998-09-29 WO PCT/JP1998/004363 patent/WO1999016770A1/ja not_active Application Discontinuation
- 1998-09-29 KR KR10-2000-7003362A patent/KR100389140B1/ko not_active IP Right Cessation
- 1998-09-29 PL PL98339544A patent/PL339544A1/xx unknown
- 1998-09-29 BR BRPI9814055-8A patent/BR9814055B1/pt not_active IP Right Cessation
- 1998-09-29 DK DK98944289T patent/DK1026167T3/da active
-
2000
- 2000-03-23 NO NO20001500A patent/NO319542B1/no unknown
-
2001
- 2001-05-22 HK HK01103502A patent/HK1032782A1/xx not_active IP Right Cessation
-
2002
- 2002-02-13 US US10/073,326 patent/US7022860B2/en not_active Expired - Fee Related
-
2004
- 2004-09-08 NO NO20043765A patent/NO20043765L/no not_active Application Discontinuation
-
2005
- 2005-11-09 US US11/269,828 patent/US7238812B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9814055B1 (pt) | composto, composição farmacêutica, uso do composto, e, processos para preparar e para produzir um composto. | |
DK1029853T3 (da) | Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler | |
DK0928788T3 (da) | Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler | |
DE60102815D1 (de) | 7-substituierte kondensierte ring-tetrazyclin- verbindungen | |
DK0699200T3 (da) | Dihalogentriazolopyrimidinderivater som fungicider | |
ATE356117T1 (de) | Derivate des n-((chinolinyl)oxy)-phenyl)- harnstoffs und des n-((chinazolinyl)oxy)-phenyl)- harnstoffs mit antitumor aktivität | |
MY140528A (en) | Spiroketal derivatives and their use as therapeutic agents for diabetes | |
ES2180477T3 (es) | Compuestos intermedios para la preparacion de derivados de oxazolidindiona y tiazolidindiona. | |
AU3415599A (en) | Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents | |
DE68926981D1 (de) | Cephemverbindungen und Verfahren zu ihrer Herstellung | |
AU1054200A (en) | Neurological disorders | |
NO973213L (no) | Nye 2-(1H)-quinolinforbindelser, fremgangsmåter ved fremstilling av slike samt farmasöytiske sammensetninger omfattende disse | |
IL112362A0 (en) | Vitamin D compounds, their preparation and pharmaceutical compositions containing them | |
ID15963A (id) | Aktivirus baru turunan pirimidindion homokarbosiklik nukleosida tersubstitusi dan metoda pembuatannya serta komposisi yang mengandung bahan yang sama sebagai bahan aktif | |
NO20003604L (no) | Nye tricykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
AR017971A1 (es) | DERIVADOS TRICíCLICOS DE TRIAZOLBENZAZEPINAS, PROCEDIMIENTO PARA PRODUCIR LOS MISMOS, COMPOSICIONES FARMACEUTICAS FORMULADAS CON DICHOS COMPUESTOS Y COMPUESTOS INTERMEDIARIOS DE APLICACION EN DICHO PROCEDIMIENTO Y LA PEPARACION DE LOS MISMOS. | |
EP0798304A4 (en) | DRUGS AGAINST TRHOMBOCYTOPENIA | |
EP1227098A4 (en) | TRIAZOLPURINE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THEM AND MEANS THAT SHOW AFFINITY TO THE ADENOSINE A3 RECEPTOR | |
EP1251129A4 (en) | PYRIMIDINE DERIVATIVES WITH ANTI-TUMOR EFFECT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL.8: C07D 487/04, C07F 9/6561, A61K 31/55, C07D 249/04, C07C 69/738, C07C 59/76, A61P 37/08 Ipc: C07D 487/04 (2007.01), C07F 9/6561 (2007.01), A61K |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/07/2009, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25D | Requested change of name of applicant approved |
Owner name: MEIJI SEIKA PHARMA CO., LTD. (JP) Free format text: NOME ALTERADO DE: MEIJI SEIKA KAISHA, LTD. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 17A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2325 DE 28-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |